Dexamethasone provided 4 mg at every 6 hours, the usual initial dose—equivalent to 400 mg of cortisol per day—is about 20 times the normal rate of endogenous production. In patients who have ...

100 - 140 mg /m 2 in 2 days intravenously HDex Dexamethasone orally: 40 mg on days 1 - 4, 9 -12 and 17 - 20 at 4-week intervals Modified HDex Dexamethasone orally: 40 mg on days 1 - 4 at 3-week ...

Can the stronger doses of Revlimid (10 mg, 15 mg, 20 mg, and 25 mg ... side effects more likely when Revlimid is taken with dexamethasone to treat multiple myeloma? Revlimid is taken with ...

An emotional distress lawsuit proceeded with the plaintiff claiming an endocrinologist prescribed dangerously high ...

Source: Science Source Images The IFM2017-03 trial, which showed positive results with a dexamethasone-sparing regimen, is “one of the most practice-changing” studies presented at ASH 2024 ...

During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

Patients in the BVd arm received belantamab mafodotin at 2.5 mg/kg every 3 weeks, given in combination with bortezomib and dexamethasone ... visual acuity to 20/50 or worse, and 2% had a decrease ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

US FDA approves Opdivo Qvantig injection, for subcutaneous use in most previously approved adult, solid tumour Opdivo indications: Princeton, New Jersey Monday, December 30, 2024, ...

T he treatment landscape for multiple myeloma is evolving rapidly, with novel therapies offering renewed hope for patients ...